| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 55.1289 | 60 |
| GSM780708 | Untreated after 4 days (C2_1) | 51.7471 | 53 |
| GSM780709 | Untreated after 4 days (C3_1) | 38.1436 | 3 |
| GSM780719 | Untreated after 4 days (C1_2) | 51.9454 | 54 |
| GSM780720 | Untreated after 4 days (C2_2) | 48.5731 | 43 |
| GSM780721 | Untreated after 4 days (C3_2) | 43.4952 | 20 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 50.7902 | 51 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.127 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 42.9357 | 17 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 45.2244 | 28 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 43.7154 | 21 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.606 | 53 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 52.2789 | 55 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 46.1488 | 33 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 47.7938 | 40 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.7791 | 40 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 48.9792 | 45 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 48.6852 | 44 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 51.3576 | 52 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 46.4428 | 34 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 54.2541 | 58 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 53.6589 | 57 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 48.8127 | 44 |